Clinical Predictors of 3-Months Isoniazid Rifapentine (3HP) - Related Adverse Drug Reactions (ADR) During Tuberculosis Preventive Therapy. (PAnDoRA-3HP study): An Observational Study Protocol

Christine Sekaggya-Wiltshire, Irene Mbabazi, Ruth Nabisere-Arinaitwe, Grace Banturaki, Lucy Alinaitwe, Brian Otalo, Florence Aber, Juliet Nampala, Rogers Owor, Josephine Bayiga, Eva Laker Agnes Odongpiny, Barbara Castelnuovo, Jonathan Mayito, Moorine Sekadde, Jotam G. Pasipanodya, Stavia Turyahabwe, Stella Zawedde-Muyanja
doi: https://doi.org/10.1101/2024.06.01.24308310

Article usage

Article usage: June 2024 to June 2025

AbstractFullPdf
Jun 20243401896
Jul 202480555
Aug 202450230
Sep 202441521
Oct 202445027
Nov 202420218
Dec 202423216
Jan 202531218
Feb 2025231315
Mar 202534919
Apr 202538414
May 202531621
Jun 2025414
Back to top
Posted June 02, 2024.
Download PDF
Data/Code
Email
Clinical Predictors of 3-Months Isoniazid Rifapentine (3HP) - Related Adverse Drug Reactions (ADR) During Tuberculosis Preventive Therapy. (PAnDoRA-3HP study): An Observational Study Protocol
Christine Sekaggya-Wiltshire, Irene Mbabazi, Ruth Nabisere-Arinaitwe, Grace Banturaki, Lucy Alinaitwe, Brian Otalo, Florence Aber, Juliet Nampala, Rogers Owor, Josephine Bayiga, Eva Laker Agnes Odongpiny, Barbara Castelnuovo, Jonathan Mayito, Moorine Sekadde, Jotam G. Pasipanodya, Stavia Turyahabwe, Stella Zawedde-Muyanja
medRxiv 2024.06.01.24308310; doi: https://doi.org/10.1101/2024.06.01.24308310
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area